Semaglutide for Weight Loss
US$ 28.23
tirzepatide release date Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide / Niacinamide Injection |
Description
One real-world evidence study found that patients receiving GLP-1 receptor agonists had a higher risk of ulcerative colitis compared to those on DPP-4 inhibitors (a different diabetes drug class)
4 Real-world evidence Real-world data shows encouraging results
doi: 10.1038/labinvest.3700491 60
2021;10:e019995
Signs of Accidental Vein Injection and Immediate Symptoms If semaglutide enters a blood vessel instead of fatty tissue, symptoms may appear within minutes rather than hours
Accessed April 17, 2026
